Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer

Clinical Lung Cancer

Volumn 15, Issue 1, 2014, Pages 79-85

  Geiger, Geoffrey A ^a   Kim, Miranda B ^a   Xanthopoulos, Eric P ^a   Pryma, Daniel A ^a   Grover, Surbhi ^a   Plastaras, John P ^a   Langer, Corey J ^a   Simone II, Charles B ^a   Rengan, Ramesh ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemoradiotherapy; Disease progression; Locally advanced; Stage migration; Will Rogers

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; TREATMENT PLANNING;

CHEMORADIOTHERAPY; DISEASE PROGRESSION; LOCALLY ADVANCED; STAGE MIGRATION; WILL ROGERS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84891824979     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.08.004     Document Type: Article

References (21)

1. Group USCSW. United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Available at: http://www.cdc.gov/cancer/npcr/uscs/ 2007/about.htm.
2. S. Kligerman, and S. Digumarthy Staging of non-small cell lung cancer using integrated PET/CT AJR Am J Roentgenol 193 2009 1203 1211
3. U. Nestle, S. Kremp, and A.L. Grosu Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives Radiother Oncol 81 2006 209 225
4. M. MacManus, and R.J. Hicks The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review Int J Radiat Oncol Biol Phys 72 2008 1298 1306
5. E.R. Salomaa, S. Sallinen, and H. Hiekkanen et al. Delays in the diagnosis and treatment of lung cancer Chest 128 2005 2282 2288
6. L. Wang, C.R. Correa, and J.A. Hayman et al. Time to treatment in patients with stage III non-small cell lung cancer Int J Radiat Oncol Biol Phys 74 2009 790 795
7. S.G. Jennings, H.T. Winer-Muram, and M. Tann et al. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements Radiology 241 2006 554 563
8. D.V. Eastham, D. Weerasuriya, and H. Wakelee et al. Quantification of progression of non-small cell lung cancer in the interval between diagnostic and radiotherapy treatment planning PET scans Int J Radiat Oncol Biol Phys 69 2007 S520 S521 Available at: http://linkinghub.elsevier.com/retrieve/pii/ S0360301607030313?showall=true
9. M. MacManus, M. Bayne, and S. Everitt et al. High incidence of progression of non-small cell lung cancer between staging and treatment-planning FDG-PET/CT scans in candidates for radical radiation therapy Int J Radiat Oncol Biol Phys 66 2006 S463 Available at: http://linkinghub.elsevier.com/retrieve/ pii/S0360301606021055?showall=true
10. S. Vinod, and A. Kaplan Growth of non-small cell lung cancer from diagnosis to radiotherapy treatment Lung Cancer 49 2005 S315 Available at: http://www.sciencedirect.com/science/article/B6T9C-4H0T0S7-1CS/2/ cdfe6c0afac9ec3d27c7790ccb9372aa
11. N. O'Rourke, and R. Edwards Lung cancer treatment waiting times and tumour growth Clin Oncol (R Coll Radiol) 12 2000 141 144
12. N. Mohammed, L.L. Kestin, and I.S. Grills et al. Rapid disease progression with delay in treatment of non-small-cell lung cancer Int J Radiat Oncol Biol Phys 79 2011 466 472
13. S. Everitt, A. Herschtal, and J. Callahan et al. High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with non-small cell lung cancer Cancer 116 2010 5030 5037
14. P.H. Jarritt, A.R. Hounsell, and K.J. Carson et al. Use of combined PET/CT images for radiotherapy planning: initial experiences in lung cancer Br J Radiol 28 suppl 2005 33 40
15. H.A. Nabi, and J.M. Zubeldia Clinical applications of (18)F-FDG in oncology J Nucl Med Technol 30 2002 3 9 quiz 10-11
16. N. Saint-Jacques, D. Rayson, and T. Al-Fayea et al. Waiting times in early-stage non-small cell lung cancer (NSCLC) J Thorac Oncol 3 2008 865 870
17. S. Everitt, N. Plumridge, and A. Herschtal et al. The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer Radiother Oncol 106 2013 288 291
18. C.T. Muijs, J. Pruim, and J.C. Beukema et al. Oesophageal tumour progression between the diagnostic 18F-FDG-PET and the 18F-FDG-PET for radiotherapy treatment planning Radiother Oncol 106 2013 283 287
19. R. Bütof, and M. Baumann Time in radiation oncology - keep it short! Editorial Board Radiother Oncol 106 2013 271 275
20. Z. Chen, W. King, and R. Pearcey et al. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature Radiother Oncol 87 2008 3 16
21. R. Sasaki, R. Komaki, and H. Macapinlac et al. fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer J Clin Oncol 23 2005 1136 1143